Pharma Anti-Counterfeiting 2012

“Competences to Combat Counterfeits in EU & U.S.”

18th October 2012, London Marriott Marble Arch Hotel, London, UK

 

CONFERENCE BOOKING DETAILS:-

Standard Price Conference Delegate Pass (£ 500 + VAT per delegate) – You can simply email or call and book your conference delegate seats on TEL: + 44 20 3302 4659. Email – delegate.uk@virtueinsight.com

Group Discounts 2 and more Delegates – (£ 400 + VAT per delegate)

Conference Sponsor & Exhibition Stall Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to –TEL: + 44 20 3302 4659. Email - sponsor.uk@virtueinsight.com

CONFERENCE INTRODUCTION:-

Counterfeit Pharmaceuticals do not only provoke immense economic damage to pharmaceutical companies but are a great risk to the public. The increasing threat calls for immediate action against counterfeit medicines. Steps must be taken by governmental and international authorities as well as by every single affected pharmaceutical company. Counterfeit APIs and medicines pose a growing threat to patients worldwide, with increasing numbers in Europe and the USA. Customs all over the world find more and more illegally produced drugs. Moreover, drugs are increasingly sold via the Internet making it much easier to put counterfeits into circulation.

Counterfeiting of drugs and medical devices cost the pharmaceutical and medical device industry billions of dollars annually in lost revenues. This loss is amplified by the serious threats fake drugs pose to the health and safety of consumers. Directing your organization toward an successful brand protection system can be a daunting task given the sophistication of counterfeiters and the difficulty in tracking and prosecuting perpetrators. This in-depth workshop will teach you how to ensure you have a solid counterfeit program and help you to gain a better understanding of how to develop an efficient brand protection program. It is estimated that counterfeiting is a $600 billion a year problem. In fact, it’s a problem that has grown over 10,000% in the past two decades, in part fuelled by CONSUMER DEMAND. The real truth is people who purchase counterfeit merchandise risk funding nefarious activities, contributing to unemployment, creating budget deficits and compromising the future of this country in the global economy.

The real truth is counterfeiters are hardened criminals, exploiting consumers, businesses both large and small, inventors and artists and children labouring in sweatshops in Third World countries.

The Facts:

  • Counterfeiting costs U.S. businesses $200 billion to $250 billion annually.
  • Counterfeit merchandise is directly responsible for the loss of more than 750,000 American jobs.
  • Since 1982, the global trade in illegitimate goods has increased from $5.5 billion to approximately $600 billion annually.
  • Approximately 5%-7% of the world trade is in counterfeit goods.
  • U.S. companies suffer $9 billion in trade losses due to international copyright piracy.
  • Counterfeiting poses a threat to global health and safety.

This conference will gather government bodies, pharmaceutical companies and solution and technology providers to discuss the in-depth insights into the strategies and cutting edge technologies for pharmaceutical anti-counterfeiting.

It gives us immense pleasure in welcoming you to “Pharma Anti-Counterfeiting 2012 - Competences to Combat Counterfeits in EU & USA”

KEY THEMES DISCUSSED AT THIS CONFERENCE:-

  • Anti-Counterfeiting and Product Security in EU and USA: government policies & strategies
  • Identifying current developments in counterfeits & ways to overcome threats 
  • Discovering successful business models - Opportunities & Challenges
  • Identify main challenges and methods to improve Global Security
  • International partnerships and EU & U.S. regulations to combat counterfeit medicines
  • Practical Tips - Strategies for securing the supply chains of the 21st century - authentication, digital serialization, track and trace technologies and government enforcement
  • Best Practices on risk based approach to predict & prevent counterfeiting
  • Protect your products - Learn how to use the right packaging identification systems effectively
  • Discuss the impact of parallel trade and re-imports on counterfeiting medicines
  • Effective drug packaging design and technologies enhancing product efficiency, patient and health personnel security, compliance, ease of use
  • Establish robust pharmaceutical anti-counterfeiting and brand protection strategy to protect product and brand revenue
  • Involve the latest cutting edge serialisation & track & trace technologies for anti-counterfeiting
  • Include anti-counterfeiting in your business plan in order to secure product and supply chain safety in your company
  • How the FBI is currently addressing intellectual property crime and partnering with U.S. government agencies
  • Network in our combined exhibition and catering area
  • Evening networking reception for all attendees

KEY SPEAKERS:-

  • Ed Wheatley, Regional Investigations Director EMEA, Global Security, AstraZeneca
  • Wendy Greenall, Counterfeit Medicines Laboratory Manager – EMEA, Pfizer
  • Tomasz Dzitko, CEO, Delfarma
  • Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office
  • Monika Derecque-Pois, Director General, European Association of Pharmaceutical Full-Line Wholesalers (GIRP)
  • Mustafa A. Zaman, Senior Consultant – Integrated Product Development (IPD), Parexel
  • Jim Thomson, Chair, European Alliance for Access to Safe Medicines (EAASM)
  • Mark Davison, CEO, Blue Sphere Health
  • Olgun Yenersoy,
 CEO, ADVANCO
  • Tanvi Goel, EGA representative – Global Serialization Manager, Mylan Pharmaceuticals
  • Neil Lawrence, AIDC Programme Lead – Department of Health, NHS
  • Maarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association)
  • Marietta Ulrich-Horn, General Manager, Securikett

WHO WILL YOU MEET:-

Brand Protection & Enforcement Units

VPs, Heads, Directors and Managers with the following responsibilities:

  • Anti-Counterfeiting Operations
  • Brand Protection
  • Brand Enforcement
  • Brand Security
  • Brand Integrity
  • Brand Management
  • Corporate Security
  • Global Security
  • Intellectual Property
  • Trademark Protection

Supply Chain

VPs, Heads, Directors and Managers with the following responsibilities:

  • Supply Chain
  • Product Safety, Regulation & Quality
  • Quality Assurance
  • Track and Trace
  • Manufacturing Tec

WHY SHOULD YOU ATTEND:-

“Pharma Anti-Counterfeiting 2012 - Competences to Combat Counterfeits”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

08:30 – Coffee and registration

09:20 – Morning Chair’s opening remarks

Mark Davison, CEO, Blue Sphere Health

09:30 – Morning Keynote Address 1: ''Combating Counterfeiting of Medicines, Identifying Key Problems and
Proposing Key Solutions''

  • What is a Counterfeit Drug and the reasons for its growth.
  • The economic Impact of Counterfeit Drugs
  • The aim and the objective of the FMD
  • EGA's Standpoint on FMD
  • The 3 key princples supported by EGA
  • Online Pharmacies and Parallel Trading - Main source of Counterfeit
  • Drugs today

Tanvi Goel, EGA representative – Global Serialization Manager, Mylan Pharmaceuticals

10:00 – Morning Keynote Address 2: "Case studies of counterfeit medicines entering the legitimate Supply Chain from an AstraZeneca perspective”

  • Specific AstraZeneca case studies involving counterfeit medicines and the supply chain
  • Examples from UK and across EMEA region
  • How AZ manages the issue of “Supply Chain Integrity”
  • Key risks and how AZ mitigate them

Ed Wheatley, Regional Investigations Director EMEA, Global Security, AstraZeneca

10:30 – Morning Keynote Panel Discussion: Challenges and Opportunities

As globalization has created more steps between production and consumption of pharmaceuticals, manufacturers have implemented various approaches to detect and prevent counterfeit products. A combination of anti-tamper, serialization and authentication technologies can be used to detect real versus counterfeit products, creating several layers of security for original pharmaceutical producers.

  • The Dark Side of Globalization: Conquering counterfeit medicine now requires a global solution
  • Advice to brand owners about how to coordinate/participate in government efforts
  • Internet Buying: Is it so Dangerous? How to make it safer and thus bring the benefits of Internet prices to all.
  • Identifying the scope of the problem of counterfeit medicines and medical devices

Moderator –

Mark Davison, CEO, Blue Sphere Health

Panelists –

Mustafa A. Zaman, Senior Consultant – Integrated Product Development (IPD), Parexel

Neil Lawrence, AIDC Programme Lead - Department of Health, NHS

11:10 – Morning Coffee & Networking

11:30 – The real life experience in the Health care Supply chain

  • The reform in the Healthcare Supply Chain including all stakeholders
  • Experience in Turkey
  • Manufacturers’ problems, both for production and warehousing with serialization
  • Wholesalers’ problems and solutions
  • Live examples
  • Point of view of business processes and the IT solution
  • Turkey’s regulation and the best practices complying with GS1 standards

Olgun Yenersoy, 
CEO, 
ADVANCO

12:00 – Combating Counterfeits Online, a patient-led approach

  • Delivering the online elements of the FMD
  • Alerting the potential victim
  • Changing behaviour
  • Communicating risk vs benefit

Jim Thomson, Chair, European Alliance for Access to Safe Medicines (EAASM)

12:30 – The GS1 System and its relationship to Anti-Counterfeiting initiatives

  • Introducing GS1 and GS1 Healthcare; who they are, what they do, current status, benefits and future trends
  • Exploring GS1 Standards and their importance to the industry
  • Identifying the relationship between GS1 Standards, Traceability and Anti-Counterfeiting initiatives

Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office

13:00 – Networking luncheon / Networking / Exhibition Visit

14:00 – Afternoon Keynote Panel Discussion: A complete methodology to brand protection – manufacturer’s standpoint

  • Securing the pharmaceutical supply chain – tactics and compliance
  • Finding the “business case” for state, federal, regulatory requirements
  • Building an internal product safety & security team
  • Developing A robust yet flexible anti-counterfeiting strategy for The modern age To ensure patient safety & reduce Ipr enforcement costs
  • Practical advice for anti-counterfeiting and brand protection
  • 2015 readiness assessment – how to ensure preparedness – pitfalls to avoid

Moderator –

Mark Davison, CEO, Blue Sphere Health

Panelists –

Wendy Greenall, Counterfeit Medicines Laboratory Manager – EMEA, Pfizer

Tanvi Goel, EGA representative – Global Serialization Manager, Mylan Pharmaceuticals

Marietta Ulrich-Horn, General Manager, Securikett

14:50 – European Medicines Verification system and the Good Distribution Practice guideline revision

  • Modalities of medicines verifications
  • System structure and governance
  • Country requirements: Interoperability and system integration
  • Challenges and economic impact of proposed new GDP guidelines on wholesale distributors

Monika Derecque-Pois, Director General, European Association of Pharmaceutical Full-Line Wholesalers (GIRP)

15:20 – Afternoon coffee & Networking

15:40 – Initiatives of Parallel Distributors in the context of Falsified Medicines Directive

  • Good Parallel Distribution Guidelines
  • Early Warning Anti-Counterfeit Platform
  • Joint Audits Initiative
  • Collaboration with other stakeholders

Tomasz Dzitko, CEO, Delfarma

16:10 – Panel Discussion: Recent legislative and regulatory developments

Pharmaceutical manufacturers, industry suppliers and governments have been uniting to combat counterfeit drugs. While international regulations and guidelines have been developed to help accomplish this, regional and local regulations vary at present. To address this issue new EU Serialization will be introduced in 2014 followed by the new FDA/California Serialization standard in 2015.  Both of these initiatives aim to harmonize coding and require manufacturer to implement serialization systems.

  • Analysing legal procedures after finding counterfeit drugs
  • Insight into initiatives to promote a global anti-counterfeiting law
  • What governments expect from brand holders when addressing IP cases
  • How businesses can partner with EU & US customs and border protection to protect their rights
  • Collaboration & Interaction between stakeholders & law enforcement - Building an interactive network with government & police for investigating & to monitor, track, trace counterfeiting drugs
  • How the FBI is currently addressing counterfeit products and IP crime

Moderator –

Mark Davison, CEO, Blue Sphere Health

Panelists –

Monika Derecque-Pois, Director General, European Association of Pharmaceutical Full-Line Wholesalers (GIRP)

Maarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association)

Tomasz Dzitko, CEO, Delfarma

16:50 – Chairperson’s closing remarks and end of conference

17:00 – 18:00 Networking Drinks Session

Organised By

Virtue insight

Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.

Silver Sponsor

Thomson Reuters

World-Check is part of the Thomson Reuters Governance, Risk and Compliance division and the Accelus suite of products. World-Check offers services effective at revealing risk that can be difficult to find. Our risk and remediation programme is used by more than 5,400 organisations in over 150 countries to meet their compliance obligations and protect the value of their reputation.

Our services include Anti Money Laundering (AML), Know Your Customer (KYC), Politically Exposed Person (PEP) screening, transaction monitoring and Enhanced Due Diligence (EDD). World-Check services extend into areas such as fraud prevention, government intelligence and enforcement, identity authentication and background screening.

The Accelus suite of solutions is designed to address governance, risk and compliance challenges faced by the board room, and by legal, compliance, audit, and risk management professionals. Besides World-Check, the Accelus suite includes leading solutions provided by the heritage businesses of Complinet, Oden, Paisley, West’s Capitol Watch, Westlaw Compliance Advisor, Westlaw Business and EDGARfilings.

Thomson Reuters Accelus helps organisations of all sizes, across all sectors, to manage their risk exposure and accelerate their business at every step.

For more information, visit: accelus.thomsonreuters.com

ByteMindz

We, The ByteMindz an emerging company incorporated with an aim of providing business solutions across Web Designing, Web Application Development, Software Development and Multimedia Services inclusive of various value-added services. We work on a diverse product line of services which are developed compatible for various frameworks, providing a complete project design and development using our high standard technical team.

We believe not only to produce exceptional in-house application we focus also on enhancing the commercial values for the customer end user applications. We extend our power of imagination across various verticals of IT services making the customer highly satisfied by providing an individual attention to each and every customer irrespective of the high, medium & large scale of organization.

Our Value Added service includes the service apart from our core standard service, we give a valuable testing unit and a complete support from our back end .We would like to hear from the customer periodically and we monitor our growth based on the customer quotes & comments and work hard on fixing those reported problems and include the fixes in our library based on the system designs and code compatible requirements. For more information log on to www.bytemindz.com

Associate Sponsor

Advanco

Advanco is a major player in the integration of solutions for Item Level Serialization and Track-and-Trace involving Automatic Identification throughout the entire supply chain. Advanco is playing an active role in the Healthcare Supply Chain Reform we are all experiencing these years.

Since its creation in 1981, Advanco has always been at the forefront of innovation. The R&D budgets invested by Advanco are well above average of the technological sector.

Today Advanco is considered as the best expert in serialization and tracking of items. Life Sciences, Food and Consumer Products sectors are covered with our proven turnkey solutions.

Advanco is focused to the Pharmaceutical Industry, and has real life references in conformity with Turkish Ministry of Health regulation mandate. Intensive R&D activities will allow Advanco to extend its expertise to Healthcare, Food and Consumer Products sectors.

Supported By

Pharmcast.com

"www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals.  www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors.  It was created and is maintained by pharmaceutical and biotechnology professionals.  Visit www.PharmCast.com and discover for yourself why it is so popular among professionals."

Business Vibes

BusinessVibes is a global B2B networking site which is home to 600+ associations and 200,000+ companies in 92 countries worldwide.We use a social networking model to promote business partnerships between companies in the US, Europe, India, China, and other major economies.

Pharmaphorum

Pharma Connections Worldwide

Technology Network

YourStory.in

Founded in 2008, YourStory.in is India’s leading and the most comprehensive online media platform for entrepreneurs and startups having a strong readership of over 250,000 unique visitors per month. YourStory.in in a short span of time has featured over 4000 entrepreneurs and startups across sector and continues to provide 360 degree online visibility through extensive profile coverage, news coverage, social media, blogs, forum, access to investors and business opportunities. YourStory.in’s audience includes entrepreneurs, startup enthusiasts, investors, developers, students, corporates, influencers, PR and advertising agencies, bloggers and journalists. Research reports published by YourStory.in are regularly picked up by leading print media houses like Mint (exclusive partner The Wall Street Journal) and The Hindu Business Line.

Clocate

Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location.  Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's  website and more...
If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you'll find it in Clocate.com.

Securing Industry

SSR Incorporating EP

“The day was well attended by a wide range of industry representatives and resulted in informative and helpful discussion.”

Ed Wheatley
Regional Investigations Director EMEA, Global Security, AstraZeneca Plc
DOWNLOAD Ulrike Kreysa, GSI
DOWNLOAD Tomasz Dzitko, Delfarma
DOWNLOAD Olgun Yenersoy, Advanco
DOWNLOAD Monika Derecque-Pois, GIRP
DOWNLOAD Jim Thomson, EAASM
DOWNLOAD Ed Wheatley, AstraZeneca

Our potent conference agenda delivering the latest information and the world class leaders as speakers attract delegates to attend from around the world. We aim for our attendees to be equipped with knowledge of latest developments and enable them to network with the industry key personnel.

To book a Delegate Place, India - delegate@virtueinsight.com United Kingdom - delegate.uk@virtueinsight.com

Designed By ByteMindz
Close
Welcome
You have been registered successfully!
Close
Close
Enter Password
Submit Close